PROCTER & GAMBLE HEALTH | CORAL LAB. | PROCTER & GAMBLE HEALTH/ CORAL LAB. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 15.0 | 230.1% | View Chart |
P/BV | x | 10.6 | 0.9 | 1,193.1% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH CORAL LAB. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
CORAL LAB. Mar-23 |
PROCTER & GAMBLE HEALTH/ CORAL LAB. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 368 | 1,458.0% | |
Low | Rs | 3,883 | 217 | 1,789.4% | |
Sales per share (Unadj.) | Rs | 740.7 | 218.8 | 338.5% | |
Earnings per share (Unadj.) | Rs | 138.2 | 18.1 | 765.7% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 24.2 | 642.2% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 433.6 | 103.2% | |
Shares outstanding (eoy) | m | 16.60 | 3.57 | 465.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.3 | 466.7% | |
Avg P/E ratio | x | 33.5 | 16.2 | 206.3% | |
P/CF ratio (eoy) | x | 29.8 | 12.1 | 246.0% | |
Price / Book Value ratio | x | 10.3 | 0.7 | 1,530.3% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 1,045 | 7,345.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 111 | 1,851.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 781 | 1,574.0% | |
Other income | Rs m | 184 | 69 | 266.7% | |
Total revenues | Rs m | 12,480 | 850 | 1,468.0% | |
Gross profit | Rs m | 3,247 | 39 | 8,433.2% | |
Depreciation | Rs m | 281 | 22 | 1,289.0% | |
Interest | Rs m | 8 | 3 | 227.1% | |
Profit before tax | Rs m | 3,142 | 82 | 3,819.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 18 | 4,757.4% | |
Profit after tax | Rs m | 2,295 | 64 | 3,560.4% | |
Gross profit margin | % | 26.4 | 4.9 | 535.8% | |
Effective tax rate | % | 27.0 | 21.6 | 124.6% | |
Net profit margin | % | 18.7 | 8.3 | 226.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 1,235 | 948.1% | |
Current liabilities | Rs m | 6,791 | 119 | 5,725.8% | |
Net working cap to sales | % | 40.0 | 143.0 | 28.0% | |
Current ratio | x | 1.7 | 10.4 | 16.6% | |
Inventory Days | Days | 263 | 231 | 113.8% | |
Debtors Days | Days | 343 | 1,094 | 31.4% | |
Net fixed assets | Rs m | 10,617 | 508 | 2,089.7% | |
Share capital | Rs m | 166 | 36 | 464.6% | |
"Free" reserves | Rs m | 7,265 | 1,512 | 480.4% | |
Net worth | Rs m | 7,431 | 1,548 | 480.0% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 1,743 | 1,280.8% | |
Interest coverage | x | 409.1 | 25.3 | 1,619.0% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.4 | 122.9% | |
Return on assets | % | 10.3 | 3.9 | 265.0% | |
Return on equity | % | 30.9 | 4.2 | 741.7% | |
Return on capital | % | 42.4 | 5.5 | 766.1% | |
Exports to sales | % | 0 | 92.1 | 0.0% | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | 719 | 0.0% | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 719 | 203.7% | |
Fx outflow | Rs m | 1,605 | 13 | 12,043.5% | |
Net fx | Rs m | -140 | 706 | -19.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 127 | 1,863.4% | |
From Investments | Rs m | -215 | -26 | 822.2% | |
From Financial Activity | Rs m | -985 | -64 | 1,532.4% | |
Net Cashflow | Rs m | 1,160 | 36 | 3,201.7% |
Indian Promoters | % | 0.0 | 20.0 | - | |
Foreign collaborators | % | 51.8 | 51.5 | 100.5% | |
Indian inst/Mut Fund | % | 20.0 | 0.1 | 14,264.3% | |
FIIs | % | 6.2 | 0.1 | 4,457.1% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 28.5 | 169.1% | |
Shareholders | 56,778 | 4,098 | 1,385.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | CORAL LAB. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -0.17% | 0.45% |
1-Month | -1.15% | -0.97% | 2.55% |
1-Year | 0.73% | 48.65% | 56.14% |
3-Year CAGR | -8.76% | -3.40% | 15.22% |
5-Year CAGR | 4.97% | 2.89% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the CORAL LAB. share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of CORAL LAB. the stake stands at 71.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of CORAL LAB..
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
CORAL LAB. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of CORAL LAB..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.